I thought we’d have a temporary lull in stories about what a catastrophic, epic failure ObamaCare was. I mean, they got their seven million (with 0.1 to spare!), what’s left to fight about?
Then, just this morning, we learn that all this chaos and mayhem was for the benefit of 1.4 million people (actually, we learned that a week ago), and we learned that no one will be allowed into ObamaCare from now till the end of the year.
As they say of bad news, so is it true of good news: it comes in threes.
People who signed up early for insurance through the new marketplaces were more likely to be prescribed drugs to treat pain, depression and H.I.V. and were less likely to need contraceptives, according to a new study that provides a much-anticipated look at the population that signed up for coverage under the new health care law.
The health of those who enrolled in new coverage is being closely watched because many observers have questioned whether the new marketplaces would attract a large share of sick people, which could lead to higher premiums and ultimately doom the new law.
The study, to be released Wednesday by the major pharmacy-benefits manager Express Scripts, suggests that early enrollees face more serious health problems and are older than those covered by their employers. The study also showed a higher use of specialty drugs, which are often used to treat diseases like cancer and rheumatoid arthritis; the use of such drugs could hint at more costly medical problems.
The facts of life are conservative. Sick people were bound to sign up for ObamaCare (especially as they were thrown off their previous plans); healthy people didn’t see the point. No matter how Obama and his jackbooted thugs talked up the plan, everyone could see that that the pig was just wearing a fetching shade of Maybelline.